US Bancorp DE Sells 124 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

US Bancorp DE lowered its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 2.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 4,172 shares of the medical instruments supplier’s stock after selling 124 shares during the period. US Bancorp DE’s holdings in Mettler-Toledo International were worth $6,257,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in MTD. Daiwa Securities Group Inc. lifted its stake in shares of Mettler-Toledo International by 36.6% in the 1st quarter. Daiwa Securities Group Inc. now owns 2,682 shares of the medical instruments supplier’s stock valued at $3,570,000 after acquiring an additional 719 shares during the last quarter. BNP Paribas Financial Markets boosted its stake in shares of Mettler-Toledo International by 6.2% during the first quarter. BNP Paribas Financial Markets now owns 28,128 shares of the medical instruments supplier’s stock valued at $37,447,000 after purchasing an additional 1,636 shares during the period. Gateway Investment Advisers LLC bought a new position in shares of Mettler-Toledo International in the second quarter worth approximately $685,000. Mediolanum International Funds Ltd purchased a new position in shares of Mettler-Toledo International in the first quarter worth $2,169,000. Finally, AIA Group Ltd raised its holdings in Mettler-Toledo International by 71.4% during the 1st quarter. AIA Group Ltd now owns 1,899 shares of the medical instruments supplier’s stock valued at $2,528,000 after buying an additional 791 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insider Activity at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 250 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total value of $350,250.00. Following the transaction, the chief financial officer now owns 4,914 shares in the company, valued at approximately $6,884,514. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, CFO Shawn Vadala sold 250 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total value of $350,250.00. Following the completion of the transaction, the chief financial officer now directly owns 4,914 shares in the company, valued at $6,884,514. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Christian Magloth sold 1,000 shares of the stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the sale, the insider now owns 734 shares in the company, valued at approximately $1,044,459.98. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on MTD shares. JPMorgan Chase & Co. upped their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Evercore ISI boosted their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. StockNews.com upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Thursday, July 11th. The Goldman Sachs Group increased their price target on shares of Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 9th. Finally, Stifel Nicolaus lifted their price objective on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a “buy” rating in a research report on Monday, August 5th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $1,363.75.

Mettler-Toledo International Stock Up 3.9 %

Shares of MTD opened at $1,342.09 on Monday. The stock has a market cap of $28.48 billion, a P/E ratio of 36.93, a P/E/G ratio of 3.78 and a beta of 1.16. The business’s 50 day moving average price is $1,403.38 and its 200-day moving average price is $1,396.81. Mettler-Toledo International Inc. has a 52 week low of $953.28 and a 52 week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 earnings per share for the quarter, beating the consensus estimate of $9.00 by $0.65. The firm had revenue of $946.75 million during the quarter, compared to the consensus estimate of $929.13 million. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. The company’s revenue was down 3.6% on a year-over-year basis. During the same period last year, the company earned $10.19 earnings per share. On average, equities analysts anticipate that Mettler-Toledo International Inc. will post 40.34 EPS for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.